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tailed), ﬁrstly in the whole study population, and secondly the pre-
deﬁned subgroup with contralateral ‘perfect match’ control.
Results: Of 26 subjects, 23 were women, 3 men; mean age was 63 years
(51-78); mean time from diagnosis 6.5 years; mean BMI 26. At baseline,
the median average pain score in the preceding 2 weeks was similar in
the intervention (6/10) and control joints (5/10). 24 subjects completed
the study. A further patient required a hand steroid injection and was
excluded from analysis. The average pain (primary outcome measure)
and worst pain scores in the intervention joint were signiﬁcantly lower
at 3 months compared with baseline (p¼0.002, p¼0.02 respectively).
Change in joint deviation on X-ray (radiologist blinded to intervention
digit) approached, but did not achieve signiﬁcance at 3 months
(p¼0.076). When nominated intervention and control joints were
compared in all 23 patients, differences did not reach signiﬁcance. In
the subgroup who had a contralateral, ‘perfect match’ control digit,
average pain was signiﬁcantly lower in the intervention joint at 3
months (p¼0.035) and extension lag was signiﬁcantly improved
(p¼0.016). However, no signiﬁcant difference in functional outcome
measures, such as active range of motion or pinch grip was evident. 2
serious adverse events occurred during the study period, neither of
which appeared to relate to the intervention.
Conclusions: DIP joint OA can lead to signiﬁcant hand pain, deformity
and disability. Short-term DIP joint splinting is a safe, simple, inex-
pensive treatment modality which reduces DIP joint pain and improves
ability to extend the digit. It does not, if carried out nightly, give rise to
non-compliance, increased stiffness or restriction of range of motion.
The lack of a suitable placebo intervention to which investigator and
patient are blinded is a recognised weakness in this type of study.
Whilst powered to detect a difference in average pain, it is likely thatSNP association results in discovery and replication cohorts.
SNP Effect allele
(Freq)
MrOS/SOF (discovery) RSI RSII GOAL Nottingham
cases/ controls OR (P) cases/ controls OR (P) cases/ controls OR (P) cases/ controls OR (P) cases/ controls OR (P)
rs788748 A (0.49) 662/ 4750 0.71 (2x10-8) 462/ 3428 0.86 (0.03) 149/ 1430 0.98 (0.88) 1291/ 783 0.85 (0.01) 1258/ 758 1.01 (0.83)a larger study population would be required to fully understand effects
of splinting on other secondary outcomes, particularly given the large
ﬂuctuations observed in control joints. Fixed splinting, for longer
periods than 3 months, may have brought about a greater change in
outcomes, albeit with a stiffer joint, but is less likely to be well-toler-
ated. Larger trials would be required to investigate this possibility.35
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Purpose: Hip osteoarthritis (HOA) is one of the most common joint
disorders and can result in pain and disability. HOA is heritable, but the
particular genes contributing to the development of HOA are not well
deﬁned. To identify genetic associations with HOA, we conducted
a two-stage genome-wide association study (GWAS).
Methods: All analyses were restricted to individuals of European
ancestry. The discovery phase was performed using radiographically
determined HOA cases and controls selected from the Osteoporotic
Fractures in Men (MrOS) Study and the Study of Osteoporotic Fractures
(SOF) (combined cases ¼ 662). HOA cases were deﬁned as Croft grade
2 or total hip replacement (THR). HOA controls were deﬁned as Croft
grade  1, maximum joint space narrowing (JSN)  1, maximumosteophytes  1, and no THR. SNPs were genotyped using the Illumina
Omni1-Quad array and approximately 2.5 million SNPs were imputed
using the HapMap reference panel. Logistic regression was performed,
and MrOS and SOF results were combined using inverse variance
weighted ﬁxed effect meta-analysis. SNP associations with P-values 
5x10-8 were examined for replication in the Rotterdam cohorts (RSI ¼
original cohort, RSII ¼ second recruitment cycle) and the GOAL and
Nottingham case-control studies. Publicly available eQTL data from
HapMap CEU lymphoblastoid cell lines were used.
Results: On average, MrOS participants (100% male) were older than
SOF participants (100% female) at the clinic visits when HOA was
assessed (MrOS: meanSD ¼ 77.55.4 years, range ¼ 69-97; SOF:
meanSD ¼ 70.95.0 years, range ¼ 65-91). In the discovery meta-
analysis, the rs788748 A allele and the rs879966 G allele were associ-
ated with decreased odds for HOA (Table 1). The two directly genotyped
SNPs were 23 kb apart and were in moderate LD (HapMap CEU r2 ¼
0.54). Neither SNP remained nominally signiﬁcant in conditional anal-
ysis, indicating dependence. Meta-analysis of the four replication
cohorts indicated that rs788748 was signiﬁcantly associated with HOA
(OR ¼ 0.91, P-value ¼ 0.01, Table 1). From eQTL data, rs788748 and
rs879966 were marginally associated with IGFBP3 expression (P-value
¼ 0.07 and 0.06, respectively), but not IGFBP1 expression (P-value ¼
0.74 and 0.34, respectively). Knockdown of IGFBP3 in the ATDC5
chondrogenesis model system resulted in a reduction of hypertrophic
markers and a reduction in type X collagen, indicating a role for IGFBP3
in chondrogenesis.
Conclusions: Results from our genetic association study and IGFBP3
functional studies provide evidence for a link between IGFBP3 and HOA.
IGFBP3 is known to be expressed in human chondrocytes and might be
an attractive candidate for further follow-up studies.36
DIO2 IS EPIGENETICALLY REGULATED BY CPG METHYLATION IN
ARTICULAR CARTILAGE
W.D. Hollander. LUMC, Leiden, NetherlandsPurpose: Genetic studies have identiﬁed the deiodinase iodothyronine
type II gene (DIO2) as osteoarthritis (OA) susceptibility gene. DIO2 is
required for the conversion of intracellular inactive thyroid hormone
(T4) into active thyroid hormone (T3). During development T3 is
required to induce terminal maturation of growth plate chondrocytes,
leading to cell hypertrophy, extracellular matrix breakdown, minerali-
zation of cartilage and the ﬁnal formation of bone. Striking similarities
between maturating chondrocytes from the growth plate and articular
chondrocytes in OA cartilage have been described. Earlier we have
observed a higher protein expression and allelic imbalance (AI) of DIO2
with the SNP rs225014, which is considered detrimental for the integ-
rity of articular cartilage. In the current study, we set out to investigate
whether this up regulation and AI is modulated epigenetically by CpG
dinucleotide methylation and/or rs225014 genotypes.
Methods: Macroscopically preserved and OA cartilage was sampled
from 48 Caucasian end stage OA patients who underwent total joint
arthroplasty of the knee (N ¼ 21) or hip (N ¼ 27). After bisulphite
treatment of isolated DNA from cartilage, CpG methylation was
measured using Epityper, Sequenom. In total 22 CpG dinucleotides were
interrogated for differential methylation between preserved and OA
cartilage. Conventional RT-qPCR was used to measure gene expression.
To identify functional features a Generalized Linear Mixed Model
(GLMM) was ﬁtted to model DIO2 expression from CpG methylation.
Fixed covariates included joint type, disease status of cartilage and
rs225014 risk allele carriage. To account for inter-individual differences
a random effect for donor was included in the model. For chromatin
immunoprecipitation (ChIP) primary chondrocytes isolated from three
OA patients were expanded for two passages.
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affected by the rs225014 risk allele and joint type (P¼ 3.6 * 10-3 and P¼
4.2 * 10-2, respectively) Furthermore, we observed a single CpG dinu-
cleotide 2 kB upstream of the DIO2 promoter that displayed a signiﬁcant
positive correlation with expression of DIO2 (P ¼ 3.3 * 10-3). In addi-
tion, this CpG dinucleotide appeared signiﬁcantly hypermethylated in
OA cartilage, compared to matched preserved cartilage (P ¼ 1.6 * 10-4)
(Figure 1). Subsequent stratiﬁcation for rs225014 genotypes revealed an
enhanced relation between methylation and expression in carriers of
the rs225014 risk allele. Further stratiﬁcation for joint type did not
reveal any major differences. ChIP on multiple chondrocyte cell lines
identiﬁed a CTCF binding site directly on the location of the identiﬁed
CpG.
Conclusions: Compelling regulatory properties of a single CpG dinu-
cleotide 2 kB upstream of the DIO2 promoter seem responsible for the
observed up regulation of DIO2 expression in OA cartilage, independent
of rs225014 genotypes. However, expression of DIO2 is additionally
modulated by rs225014 genotypes. As a result expression of DIO2 in risk
allele carriers is more sensitive to changes in methylation, indicating an
additive effect, which in turn could be causal to OA susceptibility.
Figure 1. Overview of interrogated CpG dinucleotides in the DIO2 locus. The sixth CpG
dinucleotide from region D associates signiﬁcantly with DIO2 expression (P ¼ 0.0033)
and is differentially methylated between preserved and OA cartilage (P ¼ 1.6 * 10-4).
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GENETIC RISK FACTORS FOR KNEE OA DISPLAY GOOD PREDICTIVE
POWER IN A HIGH RISK GROUP OF OVERWEIGHT AND OBESE
FEMALES
J.B. van Meurs, J. Runhaar, M. Verbiest, S. Bierma-Zeinstra. Erasmus MC,
Rotterdam, Netherlands
Purpose: Over the last few years, several genetic markers have been
identiﬁed to be robustly associated with knee osteoarthritis (OA). These
genetic markers have been identiﬁed by gathering all cases and controls
available. In general, small effect sizes of these risk factors were found,
making OA genetic risk prediction difﬁcult. However, it is known that
the association of the genetic marker with the phenotype can be
context speciﬁc. It could be that in persons with or without major
environmental risk factors, different sets of genes are important. We
therefore set out to test predictive value of DNA variants previously
identiﬁed as being associated to knee OA, in a high risk group of over-
weight and obese, middle-aged women.
Methods:
Study Sample: This study was performed within the PRevention of knee
Osteoarthritis in Overweight Females (PROOF) study. A total of 407
women met the inclusion criteria (BMI  27, no clinical knee OA (ACR
criteria), no contraindications to MRI, no rheumatic diseases), were
invited for baseline measurements. Pre-speciﬁed primary outcome was
incidence of knee OA, deﬁned by incidence of either K&L 2, joint space
narrowing of  1.0 mm or incident clinical knee OA (ACR criteria). After
2.5 years of follow-up, forty-three women (11%) were lost to follow-up
and for a further 72 women no DNA was available.
DNA-variants: We studied DNA variants that have been reported as
being associated with knee OA at genome-wide signiﬁcance level
(P<5x10-8) in women. These included variants in or near: GDF5
(rs143383), GNL3 (rs11177) and DUS4L (also referred to as the Chr 7
locus, rs4730250) and MCF2L (rs11842874). The assay for the MCF2L
variant failed due to technical problems. We subsequently computed
a genetic risk score for the 3 variants that were genotyped successfully,
where the number of carried risk alleles where added per person.
Association between the genetic markers, the genetic risk score andincident knee OAwas tested bymultivariate logistic regression analysis,
adjusting for age and BMI.
Results: In total 92 (31%) women developed OA during the 2.5 year
follow-up time. When the risk for the separate DNA variants were
tested, for all three variants we found increased risk for incident knee
OA with the previously identiﬁed risk allele (OR(95% CI): GDF5: 1.30
(0.91-1.85); GNL3: 1.23(0.86-1.78); Chr7: 1.75(1.10-2.77)). All these risks
were at least twice as large as compared to those previously reported in
large meta-analysis. However, only the odds ratio for the chr 7 locus
reached nominally signiﬁcance (p¼0.018). The genetic risk score, which
was composed of the three SNPs under study, was signiﬁcantly asso-
ciated with incident knee OA (p¼0.007). With each additional risk
allele, the women had 38% more chance for incident knee OA. Whenwe
stratiﬁed the women into 3 groups according to their genetic risk score,
we observed that womenwith 4 or 5 genetic risk alleles had almost 3.5
times higher risk for incident knee OA compared to women that had
0 or 1 risk allele (OR 3.45 (95%CI 1.41-8.47), p¼0.007).
Conclusions: The previously identiﬁed genetic risk markers for knee
OA, were signiﬁcantly associated with incident knee OA in this high risk
group of overweight and obese women. The effect sizes of the studies
DNA variants were larger than those reported previously. These results
indicate that genetic prediction of OA can be dependent on the presence
of other strong clinical risk factors38
THE MTDNA HAPLOGROUPS INFLUENCE THE PROGRESSION OF
OSTEOARTHRITIS (OA). DATA FROM THE OSTEOARTHRITIS
INITIATIVE (OAI)
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Purpose: The Osteoarthritis Initiative (OAI) is a multicentre study
focused on identifying and evaluating risk factors of knee osteoarthritis
(OA). Previous studies carried out by our group showed the role of the
mitochondrial DNA (mtDNA) haplogroups on the prevalence and
progression of OA. The aim of this study is to replicate our previous
ﬁndings about the inﬂuence of the mtDNA haplogroups on OA
progression in the well characterized cohort of the OAI.
Methods: Data for these analyses are from the OAI public use data
set(s), and assigned the mtDNA haplogroups in 891 Caucasian samples
of the progression subcohort.
We analyzed the inﬂuence of mtDNA haplogroups on OA progression
attending to KL grade, joint space narrow (JSN), presence of osteophytes
and subchondral sclerosis in media tibial compartment, between
baseline and visit 6 (48 months). The progression criteria for KL grade
consisted in an increase of at least one (KL or OARSI) grade to any visit
and any knee; for JSN we considered progression if an increase in score
by a grade above or equal to 0.5 of the OARSI scale to any visit and any
knee occurred. Additionally we also analyzed the inﬂuence of these
mitochondrial polymorphisms on quantitative measurements of carti-
lage morphology from magnetic resonance imaging (MRI) scans: mean
cartilage thickness and volume of cartilage in medial tibia. Appropriate
statistical analyses adjusting by gender, age and body mass index (BMI)
at baseline were carried out using SPSS software (v.19).
Results: Carriers of the mtDNA haplogroup T are at lower risk for KL
grade progression (27.1 % progressors) than carriers of the most
common mtDNA haplogroup H (46.9% progressors) (OR¼0.442;
CI¼0.233-0.835; p¼0.012). As expected, carriers of the haplogroup T are
also better progressors, attending to osteophytes (35.2% progressors)
and subchondral sclerosis (30.2% progressors) in tibia medial
compartment, than carriers of the haplogroup H (53.4% progressors and
45.8% progressors respectively) (OR¼0.481; CI¼0.258-0.897; p ¼ 0.021
and OR¼0.525; CI¼0.275-1.004; p ¼ 0.05 respectively). Regarding to
JSN, carriers of the haplogroup T also showed a better progression
(23.3% progressors) than carriers of the haplogroup H (36.9% pro-
gressors) (OR¼0.510; CI¼0.261-0.995; p ¼ 0.048).
The analyses of quantitative measurements of cartilage morphology
revealed that carriers of the haplogroup T showed a higher mean
cartilage thickness in medial tibia (1.88 mm  0.28) than carriers of the
haplogroup H (1.74 mm 0.27) (borderline p¼ 0.077), as well as higher
